Which has the lower trailing P/E, ABBV or ABT?

ABT has the lower trailing P/E: ABBV trades at 129.20 and ABT at 34.51. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or ABT?

Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus ABT at 2.98%.

Does ABBV or ABT pay a bigger dividend?

ABBV yields 2.56% and ABT yields 2.27% based on trailing dividends and the latest price.

Is ABBV or ABT more profitable?

ABT runs the higher net margin — ABBV at 5.79% versus ABT at 11.65%.

How have ABBV and ABT total returns compared?

Over the past 10 years, ABBV delivered 19.90% and ABT delivered 11.29% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Abbott Laboratories (ABT)

A side-by-side comparison of AbbVie Inc. and Abbott Laboratories across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$465.69B

$263.58HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT

ABT

Abbott Laboratories

$188.16B

$108.03HealthcareDelayed quote: Jul 29, 2026, 3:59 PM EDT

Total return — ABBV vs ABT

growth of $100 · dividends reinvested · last 14y

ABBV +1197.1%ABT +355.2%ABBV compounded faster

ABBV ABT

ABBV vs ABT: by the numbers

•ABBV is the larger company ($465.69B vs $188.16B market cap).
•ABT trades at the lower trailing earnings multiple (34.51 vs 129.20 P/E), one valuation lens rather than an overall verdict.
•ABT converts more revenue to profit (11.65% vs 5.79% net margin).
•ABBV grew revenue faster over the past five years (4.59% vs 2.98% CAGR).
•ABBV pays the higher dividend yield (2.56% vs 2.27%).

Metrics side by side

Valuation

Metric	ABBV	ABT
P/E ratio	129.20	34.51
Forward P/E	N/A	19.47
P/S ratio	7.44	4.02
P/B ratio	17.00	3.60
PEG ratio	N/A	4.20
EV / EBITDA	20.92	21.69
FCF yield	4.46%	3.94%

Profitability

Metric	ABBV	ABT
Gross margin	70.68%	56.80%
Operating margin	27.60%	17.03%
Net margin	5.79%	11.65%
ROE	13.23%	10.42%
ROIC	12.97%	8.43%

Dividends

Metric	ABBV	ABT
Dividend yield	2.56%	2.27%
Payout ratio	284.39%	65.24%

Growth (annualized)

Metric	ABBV	ABT
Revenue CAGR (5Y)	4.59%	2.98%
EPS CAGR (5Y)	-2.79%	8.22%
FCF CAGR (5Y)	3.24%	5.26%
Total return CAGR (5Y)	21.73%	-0.37%

Frequently asked

Which has the lower trailing P/E, ABBV or ABT?: ABT has the lower trailing P/E: ABBV trades at 129.20 and ABT at 34.51. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or ABT?: Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus ABT at 2.98%.
Does ABBV or ABT pay a bigger dividend?: ABBV yields 2.56% and ABT yields 2.27% based on trailing dividends and the latest price.
Is ABBV or ABT more profitable?: ABT runs the higher net margin — ABBV at 5.79% versus ABT at 11.65%.
How have ABBV and ABT total returns compared?: Over the past 10 years, ABBV delivered 19.90% and ABT delivered 11.29% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full ABT analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Abbott Laboratories P/E ratio AbbVie dividend yield Abbott Laboratories dividend yield AbbVie ROE Abbott Laboratories ROE AbbVie operating margin Abbott Laboratories operating margin AbbVie revenue growth Abbott Laboratories revenue growth AbbVie free cash flow Abbott Laboratories free cash flow

AbbVie & Abbott Laboratories appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.